scholarly article | Q13442814 |
P50 | author | Annamaria Vezzani | Q66943699 |
P2093 | author name string | Valentina Iori | |
Federica Frigerio | |||
P2860 | cites work | Astrocyte immune responses in epilepsy | Q37983788 |
The role of inflammation in epileptogenesis | Q38004250 | ||
Glia and epilepsy: excitability and inflammation | Q38072496 | ||
P2X7 receptor in epilepsy; role in pathophysiology and potential targeting for seizure control. | Q38074161 | ||
New avenues for anti-epileptic drug discovery and development | Q38139837 | ||
How is inflammation initiated? Individual influences of IL-1, IL-18 and HMGB1. | Q38205589 | ||
Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability | Q38274853 | ||
Anti-inflammatory drugs in epilepsy: does it impact epileptogenesis? | Q38341967 | ||
A systematic nomenclature for the redox states of high mobility group box (HMGB) proteins | Q38532707 | ||
A novel anticonvulsant mechanism via inhibition of complement receptor C5ar1 in murine epilepsy models | Q41436690 | ||
CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity | Q43653561 | ||
Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures | Q43943116 | ||
Interleukin-1β Enhances NMDA Receptor-Mediated Intracellular Calcium Increase through Activation of the Src Family of Kinases | Q44595357 | ||
Inflammation exacerbates seizure-induced injury in the immature brain | Q46521208 | ||
Microglia-dependent alteration of glutamatergic synaptic transmission and plasticity in the hippocampus during peripheral inflammation. | Q48088648 | ||
Complement activation in experimental and human temporal lobe epilepsy | Q48215408 | ||
Formation of complement membrane attack complex in mammalian cerebral cortex evokes seizures and neurodegeneration. | Q48393173 | ||
Stimulation of excitatory amino acid release from adult mouse brain glia subcellular particles by high mobility group box 1 protein. | Q48446471 | ||
Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy | Q48455854 | ||
GABAA currents are decreased by IL-1β in epileptogenic tissue of patients with temporal lobe epilepsy: implications for ictogenesis | Q48574002 | ||
Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis | Q48693638 | ||
Disulfide-containing high mobility group box-1 promotes N-methyl-D-aspartate receptor function and excitotoxicity by activating Toll-like receptor 4-dependent signaling in hippocampal neurons | Q48957875 | ||
The dual role of TNF-α and its receptors in seizures. | Q50961431 | ||
Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. | Q53278044 | ||
Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis | Q60535512 | ||
Interleukin-1 type 1 receptor/Toll-like receptor signalling in epilepsy: the importance of IL-1beta and high-mobility group box 1 | Q63384072 | ||
Cyclooxygenase-2 in epilepsy. | Q26827095 | ||
Role of microglia in CNS inflammation | Q27023760 | ||
Cytokines and acute neurodegeneration | Q28190084 | ||
Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha | Q28241574 | ||
IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures | Q28308260 | ||
Control of synaptic strength by glial TNFalpha | Q28570361 | ||
DAMPs, PAMPs and alarmins: all we need to know about danger | Q29547535 | ||
Synaptic scaling mediated by glial TNF-alpha | Q29616816 | ||
Mechanisms underlying inflammation in neurodegeneration | Q29617977 | ||
Toll-like receptor 4 enhancement of non-NMDA synaptic currents increases dentate excitability after brain injury | Q30392483 | ||
Learning and memory ... and the immune system | Q30410489 | ||
Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors | Q30487868 | ||
Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances. | Q30741122 | ||
Potentiation of NMDA receptor-dependent cell responses by extracellular high mobility group box 1 protein | Q34406782 | ||
TRPV1. | Q34416647 | ||
Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice | Q35314740 | ||
Toll-like receptor 4 signaling: A common pathway for interactions between prooxidants and extracellular disulfide high mobility group box 1 (HMGB1) protein-coupled activation | Q36145679 | ||
Interleukin-1 and neuronal injury | Q36202191 | ||
Cytokines and brain excitability. | Q36542185 | ||
Opposing actions of hippocampus TNFα receptors on limbic seizure susceptibility | Q36794661 | ||
The redox state of the alarmin HMGB1 is a pivotal factor in neuroinflammatory and microglial priming: A role for the NLRP3 inflammasome | Q36814026 | ||
Cytokines and neuronal ion channels in health and disease. | Q36902293 | ||
Pro-inflammatory cytokines and their effects in the dentate gyrus | Q36926845 | ||
Role of brain inflammation in epileptogenesis | Q37040824 | ||
A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta | Q37300227 | ||
The cortical innate immune response increases local neuronal excitability leading to seizures | Q37319554 | ||
Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability | Q37608742 | ||
The role of inflammation in epilepsy | Q37816957 | ||
Inflammation in epilepsy: clinical observations | Q37872029 | ||
Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system | Q37897498 | ||
Towards an integrated view of HCN channel role in epilepsy. | Q37904129 | ||
P304 | page(s) | 118-123 | |
P577 | publication date | 2015-11-26 | |
P1433 | published in | Current Opinion in Pharmacology | Q3007702 |
P1476 | title | Modulation of neuronal excitability by immune mediators in epilepsy | |
P478 | volume | 26 |
Q37340703 | Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside |
Q41676639 | Cryptogenic NORSE: Its distinctive clinical features and response to immunotherapy |
Q57175060 | Effects of rapamycin and curcumin on inflammation and oxidative stress in vitro and in vivo - in search of potential anti-epileptogenic strategies for temporal lobe epilepsy |
Q55220148 | Exogenous α-synuclein hinders synaptic communication in cultured cortical primary rat neurons. |
Q30846878 | Identification of brain regions predicting epileptogenesis by serial [18F]GE-180 positron emission tomography imaging of neuroinflammation in a rat model of temporal lobe epilepsy |
Q89218723 | In search of antiepileptogenic treatments for post-traumatic epilepsy |
Q38954648 | Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders |
Q60920839 | Innate Immunity Cells and the Neurovascular Unit |
Q40135696 | Innate and adaptive immunity in human epilepsies |
Q49721281 | Intrinsic Inflammation Is a Potential Anti-Epileptogenic Target in the Organotypic Hippocampal Slice Model. |
Q94461580 | MALT-1 mediates IL-17 neural signaling to regulate C. elegans behavior, immunity and longevity |
Q47839893 | Mass cytometry analysis of immune cells in the brain |
Q55228929 | NADPH oxidases as potential pharmacological targets against increased seizure susceptibility after systemic inflammation. |
Q54989642 | Persistent Protection Against Pathology and Paroxysms by P2X7R Antagonism. |
Q47945695 | Personalized translational epilepsy research - Novel approaches and future perspectives: Part II: Experimental and translational approaches. |
Q91202973 | Role of astrocyte purinergic signaling in epilepsy |
Q64894712 | Susceptibility to hippocampal kindling seizures is increased in aging C57 black mice. |
Q52314919 | The Communication Between the Immune and Nervous Systems: The Role of IL-1β in Synaptopathies. |
Q37620335 | The Cyclic Vomiting Syndrome Threshold: A Framework for Understanding Pathogenesis and Predicting Successful Treatments |
Q92257585 | The Potential Role of MicroRNA-124 in Cerebral Ischemia Injury |
Q49034139 | Upregulated P2X3 Receptor Expression in Patients with Intractable Temporal Lobe Epilepsy and in a Rat Model of Epilepsy |
Q28079067 | α-Tocopherol and Hippocampal Neural Plasticity in Physiological and Pathological Conditions |
Search more.